Vivos Therapeutics, Inc. is a medical technology company which engages in the development and commercialization of treatment alternatives for patients with sleep disordered breathing (SDB). The company is headquartered in Littleton, Colorado and currently employs 109 full-time employees. The company went IPO on 2020-12-11. The firm calls its solution The Vivos Method. The Vivos Method represents the first clinically effective nonsurgical, noninvasive and nonpharmaceutical solution for treating mild to severe OSA. The Vivos Method includes treatment regimens that employ the proprietary Complete Airway Repositioning and/or Expansion (CARE) appliance therapy and other modalities that alter the size, shape and position of the soft tissues that comprise a patient's upper airway and/or palate. The company comprises various products and services, including Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, and Vivos Airway Intelligence Service, and others.
Mr. R. Kirk Huntsman is the Chairman of the Board of Vivos Therapeutics Inc, joining the firm since 2016.
What is the price performance of VVOS stock?
The current price of VVOS is $0, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Vivos Therapeutics Inc?
Vivos Therapeutics Inc belongs to Health Care industry and the sector is Health Care
What is Vivos Therapeutics Inc market cap?
Vivos Therapeutics Inc's current market cap is $NaN
Is Vivos Therapeutics Inc a buy, sell, or hold?
According to wall street analysts, 5 analysts have made analyst ratings for Vivos Therapeutics Inc, including 2 strong buy, 4 buy, 2 hold, 0 sell, and 2 strong sell